Brief: Ceapro qtrly earnings per share $0.01
23/11/2016 12:05
Nov 23 (Reuters) - Ceapro Inc CZO.V :
* Ceapro Inc- qtrly earnings per share $0.01
* Will "commence patient recruitment for pilot clinical
study to develop beta glucan as a cholesterol reducer in Q1
2017"
* Ceapro Inc reports third quarter 2016 financial and
operational results
* Q3 sales C$3.018 million
Source text for Eikon: ID:nCCN35065v
Further company coverage: CZO.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Ceapro
See all newsBrief: Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Brief: Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris
Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company
Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
Brief: Ceapro Initiates Phase 1-2A Study Assessing Avenanthramides For Potential Applications In Inflammation Based Diseases